A client with bipolar disorder is prescribed an antidepressant medication as part of their treatment plan. Which of the following is an important consideration when administering antidepressants to individuals with bipolar disorder?

Choice A rationale:

Antipsychotics are often used to manage acute manic episodes in bipolar disorder, but they are not considered the gold standard for overall treatment. They may have a role as adjunctive therapy or in specific situations, but they are not typically the primary choice for maintenance treatment.

Choice B rationale:

Antidepressants are used in bipolar disorder treatment, but they are often cautiously prescribed due to the risk of triggering manic episodes or rapid cycling. They are not considered the gold standard due to this potential for destabilization.

Choice C rationale:

Benzodiazepines may be used to manage acute agitation or anxiety in bipolar disorder, but they are not the gold standard for long-term treatment. Prolonged use can lead to dependence and may not address the underlying mood instability.

Choice D rationale:

Mood stabilizers. Mood stabilizers like lithium, valproate (divalproex), and lamotrigine are considered the gold standard for bipolar disorder treatment due to their efficacy in managing both acute episodes (manic, hypomanic, and depressive) and providing long-term stabilization. These medications help prevent relapses and mood swings by regulating neurotransmitters and stabilizing mood fluctuations.

Choice A rationale:

The GAD-7 (Generalized Anxiety Disorder 7-item scale) is a self-report questionnaire designed to assess the severity of generalized anxiety symptoms. While anxiety and depression often coexist, the GAD-7 focuses on anxiety symptoms and wouldn't provide a comprehensive assessment of depression severity.

Choice B rationale:

The BAI (Beck Anxiety Inventory) is used to measure the severity of anxiety symptoms, not depression. It wouldn't be the appropriate tool for assessing depression in this context.

Choice C rationale:

This is the correct answer. The PHQ-9 (Patient Health naire-9) is a widely used self-report tool specifically designed to measure the severity of depressive symptoms. It covers various domains of depression, such as mood, sleep, appetite, and concentration, and is suitable for assessing the impact of depression on an individual's functioning.

Choice D rationale:

The CAGE questionnaire is used to assess alcohol misuse, not depression. It consists of four questions aimed at identifying potential alcohol-related problems. While substance use disorders can co-occur with depression, the CAGE is not the appropriate tool for assessing depression severity and impact.